{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:45:51Z","timestamp":1775911551669,"version":"3.50.1"},"reference-count":63,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Our aim was to perform a retrospective analysis of the volume of cervical screening tests, the number of patients treated with an excision method, and the incidence of invasive and non-invasive cervical during a pandemic and pre-pandemic period of 24 months. Materials and Methods: The study compared 404 patients who underwent cervical cone biopsy for cervical cancer. The study examined patients\u2019 specimens based on histopathological characteristics and categorized cervical lesions based on pap smear. Results: There was a statistically significant age difference between the two study periods. The mean difference was 32 years before the pandemic and 35 years during the pandemic (p-value &gt; 0.05). The biggest patient loss ratio identified by age group was in the 50\u201359-year group, with a 14.53% loss in the pre-pandemic period and a 9.1% loss in the pandemic period. In the pandemic period, patients from rural areas presented in the clinical trial with a lower rate of 39.52% (83 patients) vs. 60.47% (127 patients) in urban areas. A higher percentage of patients experiencing cervicorrhagia as a clinical manifestation in the pandemic period vs. the pre-pandemic period, with an increase in more severe lesions in the pandemic period, had a statistical significance of 8% more newly diagnosed compared to the pre-pandemic period. Conclusions: The addressability of the patients during the COVID period was not affected in a drastic way in our study. We encountered a decrease in appointments in the age group of 50\u201359 years and a decrease in patients with rural residence. In our study, we found an increase in cervical bleeding as a reason for consultation in the pandemic period with a higher lesion degree, both on a pap smear and on a cervical biopsy.<\/jats:p>","DOI":"10.3390\/medicina60060909","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T12:19:46Z","timestamp":1717417186000},"page":"909","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions\u2014A Single-Center Retrospective Study"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4205-1956","authenticated-orcid":false,"given":"Lavinia","family":"Balan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-3790","authenticated-orcid":false,"given":"Cristina","family":"Secosan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgiliu-Bogdan","family":"Sorop","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Pirtea","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9530-022X","authenticated-orcid":false,"given":"Anca Maria","family":"Cimpean","sequence":"additional","affiliation":[{"name":"Department of Microscopic Morphology\/Histology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Chiriac","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalin","family":"Balan","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ema","family":"Borsi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Discipline of Hematology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Iorga","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Infectious Diseases and Pulmonology \u201cDr. Victor Babes\u201d, 300310 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurentiu","family":"Pirtea","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"H80","DOI":"10.1016\/j.vaccine.2013.04.038","article-title":"Recommendations for cervical cancer prevention in central and eastern Europe and central Asia","volume":"31","author":"Poljak","year":"2013","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/ijc.25525","article-title":"Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania","volume":"128","author":"Arbyn","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_4","first-page":"229","article-title":"A Review of Cervical Cancer: Incidence and Disparities","volume":"112","author":"Buskwofie","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position Statement on Managing the Menopause after Gynecological Cancer: Focus on Menopausal Symptoms and Osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","article-title":"The IARC perspective on cervical cancer screening","volume":"385","author":"Bouvard","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.annonc.2019.11.004","article-title":"Incidence and Mortality from Cervical Cancer and Other Malignancies after Treatment of Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis of the Literature","volume":"31","author":"Kalliala","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/14760584.2018.1548282","article-title":"Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials","volume":"17","author":"Arbyn","year":"2018","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u20132099: A modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Akinyemiju, T.F. (2012). Socio-economic and health access determinants of breast and cervical cancer screening in lowincome countries: Analysis of the World health Survey. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048834"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of Cervical Cancer Mortality in the Member States of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_12","unstructured":"(2024, March 20). Cancer Today. Available online: http:\/\/gco.iarc.fr\/today\/home."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chrysostomou, A.C., Stylianou, D.C., Constantinidou, A., and Kostrikis, L.G. (2018). Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses, 10.","DOI":"10.3390\/v10120729"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3332\/ecancer.2021.1299","article-title":"Impact of the COVID-19 pandemic on breast and cervical cancer stage at diagnosis in Brazil","volume":"15","author":"Bonadio","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.lanepe.2021.100101","article-title":"The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry","volume":"5","author":"Jerman","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_16","unstructured":"Center for Systems Science and Engineering at Johns Hopkins University (2024, March 24). COVID-19 Dashboard. Available online: https:\/\/gisanddata.maps.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6."},{"key":"ref_17","unstructured":"World Health Organization (2020). Rapid Assessment of Service Delivery for Noncommunicable Diseases (NCDs) during the COVID-19 Pandemic, World Health Organization."},{"key":"ref_18","first-page":"21","article-title":"Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening","volume":"30","author":"Poljak","year":"2021","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Vahabi, M., Shahil-Feroz, A., Lofters, A., Wong, J.P., Prakash, V., Pimple, S., Anand, K., and Mishra, G. (2023). Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries. Healthcare, 11.","DOI":"10.3390\/healthcare11233079"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11864-021-00888-3","article-title":"Lessons Learned in Managing Patients with Colorectal Cancer during the COVID-19 Pandemic","volume":"22","author":"Mukherji","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00520-023-07767-7","article-title":"Disruption in Cancer Care during Early Survivorship due to the COVID-19 Pandemic and Patient Satisfaction with Telemedicine","volume":"31","author":"Bellizzi","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_22","first-page":"38","article-title":"Consequences of the COVID-19 Pandemic on Cancer Clinical Trials","volume":"4","author":"Flores","year":"2021","journal-title":"Cancer Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3332\/ecancer.2023.1598","article-title":"The lived experiences of patients with cancer during the COVID-19 pandemic: A qualitative study","volume":"17","author":"Fahed","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e10142","DOI":"10.1016\/j.heliyon.2022.e10142","article-title":"Psychological impacts of COVID-19 pandemic in cancer patients on active treatment","volume":"8","author":"Koca","year":"2022","journal-title":"Heliyon"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ijc.33884","article-title":"Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada","volume":"150","author":"Yong","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Istrate-Ofi\u021beru, A.M., Berbecaru, E.I., Ruican, D., Nagy, R.D., R\u0103mescu, C., Ro\u0219u, G.C., Iovan, L., D\u00eer\u0103, L.M., Zoril\u0103, G.L., and \u021aieranu, M.L. (2021). The Influence of SARS-CoV-2 Pandemic in the Diagnosis and Treatment of Cervical Dysplasia. Medicina, 57.","DOI":"10.3390\/medicina57101101"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Popescu, A., Craina, M., Pantea, S., Pirvu, C., Chiriac, V.D., Marincu, I., Bratosin, F., Bogdan, I., Hosin, S., and Citu, C. (2022). COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040907"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000529249","article-title":"Impact of the COVID-19 Pandemic on Cervical Cancer Screening in S\u00e3o Paulo State, Brazil","volume":"67","author":"Martins","year":"2023","journal-title":"Acta Cytol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2100371","DOI":"10.1200\/GO.21.00371","article-title":"Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in S\u00e3o Paulo, Brazil: An Interrupted Time Series Analysis","volume":"8","author":"Duarte","year":"2022","journal-title":"JCO Glob. Oncol."},{"key":"ref_30","unstructured":"(2024, March 03). AHA Letter to Surgeon General Re: Elective Surgeries and COVID-19. Available online: https:\/\/www.aha.org\/lettercomment\/2020-03-15-aha-letter-surgeon-general-re-elective-surgeries-and-covid-19."},{"key":"ref_31","unstructured":"(2024, March 03). COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures. Available online: http:\/\/www.facs.org\/covid-19\/clinical-guidance\/triage."},{"key":"ref_32","unstructured":"HealthLeaders (2024, March 14). Surgeon General Urges Providers to \u201cConsider Stopping Elective Surgeries.\u201d Hospitals Push Back. Available online: https:\/\/www.healthleadersmedia.com\/clinical-care\/surgeon-general-urges-providers-consider-stopping-elective-surgeries-hospitals-push."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12630-020-01630-7","article-title":"Safety and Efficacy of Different Anesthetic Regimens for Parturients with COVID-19 Undergoing Cesarean Delivery: A Case Series of 17 Patients","volume":"67","author":"Chen","year":"2020","journal-title":"Can. J. Anaesth."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12630-020-01637-0","article-title":"Practical Considerations for Performing Regional Anesthesia: Lessons Learned from the COVID-19 Pandemic","volume":"67","author":"Lie","year":"2020","journal-title":"Can. J. Anaesth."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1470-2045(20)30265-5","article-title":"Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands","volume":"21","author":"Dinmohamed","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/0284186X.2020.1858235","article-title":"Hidden morbidities: Drop in cancer diagnoses during the COVID-19 pandemic in Denmark","volume":"60","author":"Skovlund","year":"2021","journal-title":"Acta Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Jacob, L., Loosen, S.H., Kalder, M., Luedde, T., Roderburg, C., and Kostev, K. (2021). Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers, 13.","DOI":"10.3390\/cancers13030408"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/ijgc-2020-001975","article-title":"Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: An Austrian perspective","volume":"30","author":"Tsibulak","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/0284186X.2020.1837392","article-title":"Decreasing access to cancer diagnosis and treatment during the COVID-19 pandemic in Poland","volume":"60","author":"Maluchnik","year":"2021","journal-title":"Acta Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7004a1","article-title":"Impact of COVID-19 on cervical cancer screening rates among women aged 21\u201365 years in a large integrated health care system\u2014Southern California, January 1\u2013September 30, 2019, and January 1\u2013September 30, 2020","volume":"70","author":"Miller","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Castanon, A., Rebolj, M., Pesola, F., and Sasieni, P. (Br. J. Cancer, 2021). Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses, Br. J. Cancer, epub ahead of print.","DOI":"10.1101\/2020.11.30.20240754"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.21873\/invivo.13230","article-title":"The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review","volume":"37","author":"Elemes","year":"2023","journal-title":"In Vivo"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaoncol.2021.0884","article-title":"Association of cancer screening deficit in the United States with the COVID-19 pandemic","volume":"7","author":"Chen","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_44","first-page":"1059","article-title":"Impact of COVID-19 on cancer care: How the pandemic is delaying cancer diagnosis and treatment for American seniors","volume":"4","author":"Patt","year":"2022","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0969141320974711","article-title":"The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada","volume":"28","author":"Yong","year":"2021","journal-title":"J. Med. Screen."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13045-020-00984-1","article-title":"The Impact of the Temporary Suspension of National Cancer Screening Programmes Due to the COVID-19 Epidemic on the Diagnosis of Breast and Colorectal Cancer in the Netherlands","volume":"13","author":"Dinmohamed","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The Impact of the COVID-19 Pandemic on Cancer Deaths Due to Delays in Diagnosis in England, UK: A National, Population-Based, Modelling Study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2468-1253(21)00003-0","article-title":"Impact of the COVID-19 Pandemic on Faecal Immunochemical Test-Based Colorectal Cancer Screening Programmes in Australia, Canada, and the Netherlands: A Comparative Modelling Study","volume":"6","author":"Worthington","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000509546","article-title":"The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology","volume":"88","author":"Guiot","year":"2021","journal-title":"Pathobiology"},{"key":"ref_50","unstructured":"Modelled Analysis of Hypothetical Impacts of COVID-19 Related Disruptions on the National Cervical Screening Program (2024, March 21). Report to the Department of Health (May 2020). New South Wales: Cancer Research Division, Cancer Council NSW, Available online: https:\/\/www.health.gov.au\/resources\/publications\/modelled-analysis-of-hypothetical-impacts-of-covid-19-related-disruptions-to-the-national-cervical-screening-program."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1200\/GO.20.00654","article-title":"Impact of COVID-19 on Outcomes for Patients with Cervical Cancer in India","volume":"7","author":"Gupta","year":"2021","journal-title":"JCO Glob. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41416-021-01261-9","article-title":"Effects of cancer screening restart strategies after COVID-19 disruption","volume":"124","author":"Kregting","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_53","first-page":"17098","article-title":"Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study","volume":"11","author":"Davies","year":"2022","journal-title":"BJOG"},{"key":"ref_54","unstructured":"World Health Organisation (2023, May 25). Primary Health Care on the Road to Universal Health Coverage: 2019 Monitoring Report. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240029040."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13027-020-00325-4","article-title":"Designing low-cost, accurate cervical screening strategies that take into account COVID-19: A role for self-sampled HPV typing","volume":"15","author":"Ajenifuja","year":"2021","journal-title":"Infect. Agents Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"106595","DOI":"10.1016\/j.ypmed.2021.106595","article-title":"Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond","volume":"151","author":"Croswell","year":"2021","journal-title":"Prev. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107264","DOI":"10.1016\/j.ypmed.2022.107264","article-title":"Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care","volume":"164","author":"Ferrara","year":"2022","journal-title":"Prev. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijgo.14067","article-title":"HPV vaccination coverage in women between 15 and 55 years old in Spain: Temporal trend during the period 2007\u20132020","volume":"158","author":"Fuente","year":"2022","journal-title":"Int. J. Gynecol. Obstet"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Sabbatucci, M., Odone, A., Signorelli, C., Siddu, A., Silenzi, A., Maraglino, F.P., and Rezza, G. (2022). Childhood immunisation coverage during the COVID-19 epidemic in Italy. Vaccines, 10.","DOI":"10.3390\/vaccines10010120"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mohan, M., Appiah-Sakyi, K., Oliparambil, A., Pullattayil, A.K., Lindow, S.W., Ahmed, B., and Konje, J.C. (2023). A Meta-Analysis of the Global Stillbirth Rates during the COVID-19 Pandemic. J. Clin. Med., 12.","DOI":"10.3390\/jcm12237219"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00404-020-05909-4","article-title":"Poor maternal-neonatal outcomes in pregnant patients with confirmed SARS-CoV-2 infection: Analysis of 145 cases","volume":"303","author":"Zambrotta","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.diabet.2022.101351","article-title":"Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study","volume":"48","author":"Radan","year":"2022","journal-title":"Diabetes Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/1055-9965.EPI-19-1067","article-title":"Strengthening resilience and adaptive capacity to disasters in cancer control plans: Lessons learned from Puerto Rico","volume":"29","author":"Ortiz","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/909\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:50:43Z","timestamp":1760107843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["medicina60060909"],"URL":"https:\/\/doi.org\/10.3390\/medicina60060909","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}